How execs cash in on competitors' stocks CEOs make massive bets on the stocks of direct competitors and partners — and with exquisite timing Salon · Mar 17, 2023
Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook Syneos Health Inc's (NASDAQ:SYNH) Q1 revenue increased 10.5% on a reported basis and 11.7% on a constant currency (CC) basis to $1.34 billion, beating the consensus of $1.32 billion. Clinical Solutions revenue increased 8.4% (+9.6% CC) to $1.02 billion. Acquisitions contributed approximately 1,00 basis points to Clinical Solutions' reported revenue growth. Commercial Solutions… Benzinga · Apr 29, 2022
NOVN: A Banner Year for Novan - 2021 Results By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT Benzinga · Mar 7, 2022
Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance Syneos Health Inc's (NASDAQ: SYNH) Q4 revenue increased 20.5% on a reported basis and 20.8% on a constant currency (CC) basis to Benzinga · Feb 17, 2022